Literature DB >> 22921809

Intensity-modulated radiotherapy in anal cancer: where do we go from here?

D C Gilbert1, R Glynne-Jones.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22921809     DOI： 10.1016/j.clon.2012.06.011

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN： 0936-6555            Impact factor:   4.126


× No keyword cloud information.
  3 in total

1.  Programmed death-ligand 1 expression correlates with diminished CD8+ T cell infiltration and predicts poor prognosis in anal squamous cell carcinoma patients.

Authors:  Jun-Zhong Lin; Zhi-Zhong Pan; Yu-Jie Zhao; Wei-Peng Sun; Jian-Hong Peng; Yu-Xiang Deng; Yu-Jing Fang; Jun Huang; Hui-Zhong Zhang; De-Sen Wan
Journal:  Cancer Manag Res       Date:  2017-12-18       Impact factor: 3.989

2.  Initial Results from the Royal College of Radiologists' UK National Audit of Anal Cancer Radiotherapy 2015.

Authors:  R Muirhead; K Drinkwater; S M O'Cathail; R Adams; R Glynne-Jones; M Harrison; M A Hawkins; D Sebag-Montefiore; D C Gilbert
Journal:  Clin Oncol (R Coll Radiol)       Date:  2016-10-31       Impact factor: 4.126

Review 3.  Human papilloma virus and squamous cell carcinoma of the anus.

Authors:  Bhavna Gami; Faris Kubba; Paul Ziprin
Journal:  Clin Med Insights Oncol       Date:  2014-09-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.